Compare ImmunityBio Inc. Common Stock (IBRX) vs Iovance Biotherapeutics Inc. Common Stock (IOVA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ImmunityBio Inc. Common Stock vs Iovance Biotherapeutics Inc. Common Stock — how do they compare? ImmunityBio Inc. Common Stock trades at $10.01 (market cap $10.33B), while Iovance Biotherapeutics Inc. Common Stock trades at $13.36 (market cap $5.85B). The key difference: ImmunityBio Inc. Common Stock is the larger of the two by market cap, and Iovance Biotherapeutics Inc. Common Stock is more actively traded (14,517,176 versus 11,745,198). Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and Iovance Biotherapeutics Inc. Common Stock for 0 Days on average.
| IBRX | IOVA | |
|---|---|---|
Market Cap | $10.33B | $5.85B |
Volume | 11,745,198 | 14,517,176 |
Sector | Health | Health |
52-Week High | $11.55 | $14.82 |
52-Week Low | $1.98 | $1.81 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $10.79B | $5.78B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →
